A Multi-Center, Open-Label, Single-Arm, Prospective Investigator Initiated Trial to Evaluate the Efficacy and Safety of Alitretinoin in Patients With Chronic Hand Eczema in Real-World Practice (DWALG_P401) and Overview of Korean Studies.

Toctino (alitretinoin) - Basilea

A Multi-Center, Open-Label, Single-Arm, Prospective Investigator Initiated Trial to Evaluate the Efficacy and Safety of Alitretinoin in Patients With Chronic Hand Eczema in Real-World Practice (DWALG_P401) and Overview of Korean Studies. (PubMed, Ann Dermatol) - Aug 4, 2026 - "Oral alitretinoin at daily doses of 10 mg or 30 mg demonstrated effective symptom improvement and an acceptable safety profile in Korean patients with CHE in a real-world setting."
Journal • Real-world evidence • Atopic Dermatitis • Contact Dermatitis • Dermatology • Immunology • Pain

http://www.ncbi.nlm.nih.gov/pubmed/42547475

Byeol Han; Jee-Bum Lee; Jiehyun Jeon; Jin Woo Yu; Jiyoung Ahn; Joo Yeon Ko; Joon-Hong Min; Joung Soo Kim; Min Jung Kwon; Sul Hee Lee; Un Ha Lee; Young Lip Park

Aug 4, 2026